Literature DB >> 22958238

Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections.

Brett G Mitchell1, Anne Gardner.   

Abstract

BACKGROUND: It is believed that Clostridium difficile infection (CDI) contributes to a prolongation of length of stay (LOS). Recent literature suggests that models previously used to determine LOS due to infection have overestimated LOS, compared to newer statistical models. The purpose of this review is to understand the impact that CDI has on LOS and in doing so, describe the methodological approaches used. AIM: First, to investigate and describe the reported prolongation of LOS in hospitalised patients with CDI. Second, to describe the methodologies used for determining excess LOS.
METHODS: An integrative review method was used. Papers were reviewed and analysed individually and themes were combined using integrative methods.
RESULTS: Findings from all studies suggested that CDI contributes to a longer LOS in hospital. In studies that compared persons with and without CDI, the difference in the LOS between the two groups ranged from 2.8days to 16.1days. Potential limitations with data analysis were identified, given that no study fully addressed the issue of a time-dependent bias when examining the LOS. Recent literature suggests that a multi-state model should be used to manage the issue of time-dependent bias.
CONCLUSION: Studies examining LOS attributed to CDI varied considerably in design and data collected. Future studies examining LOS related to CDI and other healthcare associated infections should consider capturing the timing of infection in order to be able to employ a multi-state model for data analysis.

Entities:  

Year:  2012        PMID: 22958238      PMCID: PMC3436661          DOI: 10.1186/2047-2994-1-14

Source DB:  PubMed          Journal:  Antimicrob Resist Infect Control        ISSN: 2047-2994            Impact factor:   4.887


  33 in total

1.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

2.  A random time interval approach for analysing the impact of a possible intermediate event on a terminal event.

Authors:  Jan Beyersmann
Journal:  Biom J       Date:  2007-08       Impact factor: 2.207

3.  The impact of time-dependent bias in proportional hazards modelling.

Authors:  Jan Beyersmann; Martin Wolkewitz; Martin Schumacher
Journal:  Stat Med       Date:  2008-12-30       Impact factor: 2.373

4.  Estimating the cost of health care-associated infections: mind your p's and q's.

Authors:  Nicholas Graves; Stephan Harbarth; Jan Beyersmann; Adrian Barnett; Kate Halton; Ben Cooper
Journal:  Clin Infect Dis       Date:  2010-04-01       Impact factor: 9.079

5.  Effect of healthcare-acquired infection on length of hospital stay and cost.

Authors:  Nicholas Graves; Diana Weinhold; Edward Tong; Frances Birrell; Shane Doidge; Prabha Ramritu; Kate Halton; David Lairson; Michael Whitby
Journal:  Infect Control Hosp Epidemiol       Date:  2007-02-20       Impact factor: 3.254

6.  The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences.

Authors:  Judith A O'Brien; Betsy J Lahue; J Jaime Caro; David M Davidson
Journal:  Infect Control Hosp Epidemiol       Date:  2007-10-03       Impact factor: 3.254

7.  The burden of Clostridium difficile in surgical patients in the United States.

Authors:  Marc Zerey; B Lauren Paton; Amy E Lincourt; Keith S Gersin; Kent W Kercher; B Todd Heniford
Journal:  Surg Infect (Larchmt)       Date:  2007-12       Impact factor: 2.150

8.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.

Authors:  A N Ananthakrishnan; E L McGinley; D G Binion
Journal:  Gut       Date:  2007-09-28       Impact factor: 23.059

9.  Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population.

Authors:  Xiaoyan Song; John G Bartlett; Kathleen Speck; April Naegeli; Karen Carroll; Trish M Perl
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

10.  Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients.

Authors:  Erik R Dubberke; Anne M Butler; Kimberly A Reske; Denis Agniel; Margaret A Olsen; Gina D'Angelo; L Clifford McDonald; Victoria J Fraser
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more
  12 in total

Review 1.  Antimicrobial Stewardship in the Emergency Department.

Authors:  Michael Pulia; Robert Redwood; Larissa May
Journal:  Emerg Med Clin North Am       Date:  2018-09-06       Impact factor: 2.264

Review 2.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

3.  The impact of hospital-acquired infections on the patient-level reimbursement-cost relationship in a DRG-based hospital payment system.

Authors:  Klaus Kaier; Martin Wolkewitz; Philip Hehn; Nico T Mutters; Thomas Heister
Journal:  Int J Health Econ Manag       Date:  2019-06-05

4.  Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries.

Authors:  Christian Eckmann; Matthew Wasserman; Faisal Latif; Graeme Roberts; Axelle Beriot-Mathiot
Journal:  Eur J Health Econ       Date:  2013-10

5.  The impact of hospital-onset Clostridium difficile infection on outcomes of hospitalized patients with sepsis.

Authors:  Tara Lagu; Mihaela S Stefan; Sarah Haessler; Thomas L Higgins; Michael B Rothberg; Brian H Nathanson; Nicholas S Hannon; Jay S Steingrub; Peter K Lindenauer
Journal:  J Hosp Med       Date:  2014-04-09       Impact factor: 2.960

6.  The incremental cost of infections associated with multidrug-resistant organisms in the inpatient hospital setting-A national estimate.

Authors:  Kenton J Johnston; Kenneth E Thorpe; Jesse T Jacob; David J Murphy
Journal:  Health Serv Res       Date:  2019-03-12       Impact factor: 3.402

7.  Using Dog Scent Detection as a Point-of-Care Tool to Identify Toxigenic Clostridium difficile in Stool.

Authors:  Maureen T Taylor; Janine McCready; George Broukhanski; Sakshi Kirpalaney; Haydon Lutz; Jeff Powis
Journal:  Open Forum Infect Dis       Date:  2018-08-22       Impact factor: 3.835

8.  The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.

Authors:  Janne C Mewes; Michael S Pulia; Michael K Mansour; Michael R Broyles; H Bryant Nguyen; Lotte M Steuten
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

9.  Possible association between obesity and Clostridium difficile infection.

Authors:  Jason Leung; Bob Burke; Dale Ford; Gail Garvin; Cathy Korn; Carol Sulis; Nahid Bhadelia
Journal:  Emerg Infect Dis       Date:  2013-11       Impact factor: 6.883

10.  Costs of hospital-acquired Clostridium difficile infections: an analysis on the effect of time-dependent exposures using routine and surveillance data.

Authors:  Thomas Heister; Martin Wolkewitz; Philip Hehn; Jan Wolff; Markus Dettenkofer; Hajo Grundmann; Klaus Kaier
Journal:  Cost Eff Resour Alloc       Date:  2019-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.